24
Participants
Start Date
October 20, 2022
Primary Completion Date
May 27, 2024
Study Completion Date
September 11, 2024
Pegcetacoplan
Pegcetacoplan taken twice weekly as subcutaneous injection
Algemeen Ziekenhuis Klina, Brasschaat
UZ Gasthuisberg, Leuven
CHU de Liège, Liège
Weill Cornell Medicine / NewYork Presbyterian Hospital, New York
ASST degli Spedali Civili di Brescia_Presidio Ospedaliero di Brescia_U.O. Ematologia, Brescia
East Carolina University Division of Hematology/ Oncology, Greenville
Lakes Research, Miami Lakes
Universitätsklinikum Essen Klinik f. Hämatologie - Westdeutsches Tumorzentrum, Essen
University of Iowa Hospitals & Clinics - The Hemophilia Treatment Center (HTC), Iowa City
A.O.R.N. S.G. Moscati di Avellino, Avellino
"Grande Ospedale Metropolitano Bianchi - Melacrino - Morellii", Reggio Calabria
"Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello", Palermo
The Oncology Institute of Hope and Innovation, Whittier
Osaka University Hospital, Osaka
Ishikawa Prefectural Central Hospital, Kanazawa
Medical University, Vienna
St. Michael's Hospital, Toronto
Helsinki University Hospital - Comprehensive Cancer Center, Helsinki
"LTD Medinvest Institute of Hematology and Transfusiology ", Tbilisi
Ltd M. Zodelava Hematology Centre, Tbilisi
Institut f. Transfusionsmedizin - Universität Ulm, Ulm
Semmelweis Egyetem, Budapest
"FOND IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
AOU Maggiore della Carità SCDU Ematologia, Novara
Fukushima Medical University Hospital, Fukushima
University of Tsukuba Hospital, Ibaraki
Shinshu University Hospital, Nagano
Amsterdam UMC, Amsterdam
Haukeland University Hospital, Bergen
Sykehuset Østfold Kalnes, Grålum
St Olavs Hospital, Avdeling for blodsykdommer, Trondheim
Hospital Clinic de Barcelona, Barcelona
Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria
Hospital Clínico Universitario de Salamanca, Madrid
Hospital Universitario Infanta Leonor, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Virgen del Rocio, Seville
Hospital Universitario y Politecnico La Fe, Valencia
Cancer Clinical Trials Unit, Haematology -University College London -, London
Churchill Hospital, Oxford
Aichi Medical University Hospital, Nagakute
St James' University Hospital, Leeds
Royal London Hospital, London
Russell Centre for Clinical Haematology, Nottingham
Lead Sponsor
Swedish Orphan Biovitrum
INDUSTRY